Quality control of enteral nutrition therapy in cancer patients at nutritional risk

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorLEE, Ariana
dc.contributor.authorOLIVEIRA FILHO, Ronald Sousa
dc.contributor.authorCARDENAS, Thais de Campos
dc.contributor.authorOZORIO, Gislaine Aparecida
dc.contributor.authorGROPP, Juliana Pereira Lima
dc.contributor.authorWAITZBERG, Dan Linetzky
dc.date.accessioned2017-06-09T15:33:22Z
dc.date.available2017-06-09T15:33:22Z
dc.date.issued2017
dc.description.abstractIntroduction: Quality indicators in nutritional therapy (QINTs) allow for the practical assessment of quality in the management of enteral nutrition therapy (ENT) among hospitalized patients. Objective: To control ENT quality in cancer patients at nutritional risk. Methods: A prospective, observational study was performed with cancer patients over 19 years of age who had undergone exclusive ENT for at least 72 h. Nutritional Risk Screening was used to assess nutritional risk; in the presence of nutritional risk, the Subjective Global Assessment (SGA) was used. Six QINTs were applied. Results: Our study included 211 patients (mean age: 59 +/- 10 years, 67.3% men). Most common cancer diagnoses were head and neck (68.2%) and gastrointestinal (18%). Nutritional risk was identified in 93.3% (n = 197) of patients; SGA identified malnutrition in 84.2% of patients (n = 166). ENT was used for 9.7 +/- 7 days, presenting a daily deficit of-243.1 +/- 141 ml of dietary volume,-363.3 +/- 214.1 kcal, and-14.2 +/- 8.41 g of protein. Three of the six QINTs were in accordance with the proposed goal: frequency of SGA application, calculations of nutritional needs, and frequency of diarrhea. Three of the six QINTs were in disagreement with the proposed goal: ENT infused volume exceeding 70% of prescribed volume, frequency of digestive fasting exceeding 24 h, and frequency of constipation. Prescriptions for anticholinergic drugs (p = 0.023) and diuretics (p = 0.007) were associated with diarrhea. Conclusion: Nutritional risk and malnutrition are frequent among ENT cancer patients. Quality control in ENT was moderately impaired by episodes of fasting and intestinal motility disorders.
dc.description.indexMEDLINE
dc.identifier.citationNUTRICION HOSPITALARIA, v.34, n.2, p.264-270, 2017
dc.identifier.doi10.20960/nh.721
dc.identifier.eissn1699-5198
dc.identifier.issn0212-1611
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/20037
dc.language.isoeng
dc.publisherAULA MEDICA EDICIONES
dc.relation.ispartofNutricion Hospitalaria
dc.rightsopenAccess
dc.rights.holderCopyright AULA MEDICA EDICIONES
dc.subjectCancer
dc.subjectQuality indicators
dc.subjectEnteral nutrition
dc.subjectMalnutrition
dc.subjectDiarrhea
dc.subjectConstipation
dc.subject.otherneck-cancer
dc.subject.otherhospitalized-patients
dc.subject.otherguidelines
dc.subject.otherhead
dc.subject.otherprescription
dc.subject.otherradiotherapy
dc.subject.othermulticenter
dc.subject.otherindicators
dc.subject.otherdiarrhea
dc.subject.otherimpact
dc.subject.wosNutrition & Dietetics
dc.titleQuality control of enteral nutrition therapy in cancer patients at nutritional risk
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalCARDENAS, Thais de Campos:Inst Brasileiro Controle Canc, Dept Nutr, Sao Paulo, Brazil
hcfmusp.author.externalGROPP, Juliana Pereira Lima:Clin Alira, Dept Nutr, Sao Paulo, Brazil
hcfmusp.citation.scopus11
hcfmusp.contributor.author-fmusphcARIANA LEE
hcfmusp.contributor.author-fmusphcRONALDO SOUSA OLIVEIRA FILHO
hcfmusp.contributor.author-fmusphcGISLAINE APARECIDA OZORIO
hcfmusp.contributor.author-fmusphcDAN LINETZKY WAITZBERG
hcfmusp.description.beginpage264
hcfmusp.description.endpage270
hcfmusp.description.issue2
hcfmusp.description.volume34
hcfmusp.origemWOS
hcfmusp.origem.pubmed28421777
hcfmusp.origem.scieloSCIELO:S0212-16112017000200264
hcfmusp.origem.scopus2-s2.0-85018818163
hcfmusp.origem.wosWOS:000401302900004
hcfmusp.publisher.cityMADRID
hcfmusp.publisher.countrySPAIN
hcfmusp.relation.referenceBenson AB, 2004, J CLIN ONCOL, V22, P2918, DOI 10.1200/jco.2004.04.132
hcfmusp.relation.referenceBittencourt AF, 2012, NUTR CLIN PRACT, V27, P533, DOI 10.1177/0884533612449488
hcfmusp.relation.referenceMachado RRC, 2015, NUTR HOSP, V32, P1281, DOI 10.3305/nh.2015.32.3.9266
hcfmusp.relation.referenceChapple LS, 2016, CLIN NUTR, V23
hcfmusp.relation.referenceChima C S, 1997, ALIMENT PHARM THER, V11, P975
hcfmusp.relation.referenceVentura AMC, 2015, NUTR CLIN PRACT, V30, P351, DOI 10.1177/0884533614547765
hcfmusp.relation.referenceCorreia MI, 2016, CLIN NUTR
hcfmusp.relation.referenceDETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108
hcfmusp.relation.referenceSanchez RE, 2015, NUTR HOSP, V32, P1408, DOI 10.3305/nh.2015.32.4.9227
hcfmusp.relation.referenceFaisy C, 2009, BRIT J NUTR, V101, P1079, DOI 10.1017/S0007114508055669
hcfmusp.relation.referenceVerotti CCG, 2015, NUTR HOSP, V31, P2692, DOI 10.3305/nh.2015.31.6.8735
hcfmusp.relation.referenceVerotti CCG, 2012, NUTR CLIN PRACT, V27, P261, DOI 10.1177/0884533611432317
hcfmusp.relation.referenceGramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003
hcfmusp.relation.referenceHeyland DK, 2015, CLIN NUTR, V34, P659, DOI 10.1016/j.clnu.2014.07.008
hcfmusp.relation.referenceHeyland DK, 2010, JPEN-PARENTER ENTER, V34, P675, DOI 10.1177/0148607110364843
hcfmusp.relation.referenceIsosaki M, 2015, INDICADORES NUTR HOS
hcfmusp.relation.referenceKondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5
hcfmusp.relation.referenceKreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021
hcfmusp.relation.referenceLangius JAE, 2013, NUTR CANCER, V65, P76, DOI 10.1080/01635581.2013.741749
hcfmusp.relation.referenceFolguera TM, 2012, NUTR HOSP, V27, P198, DOI 10.3305/nh.2012.27.1.5557
hcfmusp.relation.referenceMartins JR, 2009, CLIN NUTR S S2, V4
hcfmusp.relation.referenceMartins JR, 2012, NUTRITION, V28, P864, DOI 10.1016/j.nut.2011.07.025
hcfmusp.relation.referenceMcClave SA, 2016, AM J GASTROENTEROL, V111, P315, DOI 10.1038/ajg.2016.28
hcfmusp.relation.referenceMcClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234
hcfmusp.relation.reference[Institut Nacional de Cancer Consenso nacional de nutricao oncologica Institute Nacional de Cancer Brasil. Ministario da Saida], 2009, CONS NAC NUTR ONC
hcfmusp.relation.reference[organizacao Cristiane Aline DAlmeida Institute Nacional do Cancer Jose de Alencar Gomes da Silva Inquerito Brasileiro de Nutricao Oncologica Brasil. Ministerio da Saude], 2013, INQ BRAS NUTR ONC I
hcfmusp.relation.referenceNasser APJ, 2009, J CRIT CARE, V24
hcfmusp.relation.referenceOliveira Filho RS, 2014, CLIN NUTR S1, V33, P59
hcfmusp.relation.referenceOliveira Filho RS, 2016, NUTR HOSP, V20, P563
hcfmusp.relation.referenceOliveiro Filho RS, 2016, J INTEGR ONCOL, V5, P156
hcfmusp.relation.referenceRaslan M, 2011, CLIN NUTR, V30, P49, DOI 10.1016/j.clnu.2010.07.002
hcfmusp.relation.referenceRibeiro Lia Mara Kauchi, 2014, Rev. bras. ter. intensiva, V26, P155, DOI 10.5935/0103-507X.20140023
hcfmusp.relation.referenceShiroma GM, 2015, NUTR CLIN PRACT, V30, P406, DOI 10.1177/0884533614567540
hcfmusp.relation.referenceSilander E, 2013, LARYNGOSCOPE, V123, P2428, DOI 10.1002/lary.23877
hcfmusp.relation.referenceWaitzberg DL, 2016, JPEN-PARENTER ENTER, V40, P73, DOI 10.1177/0148607115596159
hcfmusp.relation.referenceWaitzberg DL, 2011, TERAPIA NUTR INDICAD
hcfmusp.relation.referenceWaitzberg DL, 2008, INDICADORES QUALIDAD
hcfmusp.relation.referenceWang K, 2016, JPEN J PARENTER ENTE
hcfmusp.relation.referenceZhang ZH, 2016, ONCOTARGETS THER, V9, P2897, DOI [10.2147/OTT.S101983, 10.2147/OTT.S10983]
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication540f463a-3cdd-48c3-ae66-1000fa2327b7
relation.isAuthorOfPublicatione2035563-f29f-431d-87aa-1bd95ae9ed1a
relation.isAuthorOfPublication4d0be117-a258-4731-bc3d-bcc94299c823
relation.isAuthorOfPublication9f2c1ed4-5096-4646-9c41-2cea6edc8857
relation.isAuthorOfPublication.latestForDiscovery540f463a-3cdd-48c3-ae66-1000fa2327b7
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_LEE_Quality_control_of_enteral_nutrition_therapy_in_cancer_2017.PDF
Tamanho:
822.94 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)